- Title
- Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies
- Creators
- Nancy L Bartlett - Washington University Medical School, St Louis, MO, USARobert Chen - City of Hope, Duarte, CA, USAMichelle A Fanale - University of Texas MD Anderson Cancer Center, Houston, TX, USAPauline Brice - Hospital Saint-Louis, Paris, FranceAjay Gopal - University of Washington/Fred Hutchinson Cancer Center, Seattle, WA, USAScott E Smith - Loyola University Medical Center, Maywood, IL, USARanjana Advani - Stanford University Medical Center, Stanford, CA, USAJeffrey V Matous - Colorado Blood Cancer Institute, Denver, CO, USARadhakrishnan Ramchandren - Karmanos Cancer Institute, Detroit, MI, USAJoseph D Rosenblatt - University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL, USADirk Huebner - Takeda Pharmaceuticals International Company, Cambridge, MA, USAPamela Levine - Seattle Genetics, Inc, Bothell, WA, USALaurie Grove - Seattle Genetics, Inc, Bothell, WA, USAAndres Forero-Torres - University of Alabama at Birmingham, Comprehensive Cancer Center, Birmingham, AL, USA
- Publication Details
- Journal of hematology and oncology, Vol.7(1), pp.24-24
- Publisher
- BioMed Central
- Academic Unit
- Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology
- Language
- English
- Resource Type
- Journal article
- PMID
- 24642247
- PMCID
- PMC3994656
- Record Identifier
- 991031560960502976
Journal article
Retreatment with brentuximab vedotin in patients with CD30-positive hematologic malignancies
Journal of hematology and oncology, Vol.7(1), pp.24-24
2014-03-19
PMCID: PMC3994656
PMID: 24642247
Metrics
11 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Industry collaboration
- Domestic collaboration
- International collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.130 Lymphomas
- 1.130.132 Lymphoma
- Web Of Science research areas
- Hematology
- Oncology
- ESI research areas
- Clinical Medicine
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites